C&T Round Up for July 2024!

Issue 275 | July 26, 2024
8 min read
Capsid and Tail

This month, we recap what we learned about phage genome analysis tools, phage production pipelines, n of 1 clinical trials, and more!

What’s New

Canadian phage company Cytophage Technologies announced a collaboration with a Pan-Asian agrifood company in Singapore to expand its poultry phage product commercialization. Cytophage anticipates conducting trials with this commercial partner starting end of 2024.

CollaborationPoultryCommercialization

Nils Birkholz (University of Otago) and colleagues investigated the dual regulatory mechanisms of the Aca2 protein, showing that it represses anti-CRISPR gene expression by binding both DNA and RNA.

Anti-CRISPRRNA-binding proteinResearch paper

Florian Tesson (Institut Pasteur) and colleagues published a new paper on the DefenseFinder webservice/wiki/database for antiphage defense mechanisms, showing an updated resource with 152 identified systems.

Phage DefenseBioinformaticsResource Hub

Robby Concha Eloko (I2sysbio, University of Valencia, Spain) and colleagues modeled the interplay between Klebsiella prophages and their depolymerases, showing significant predictive ability for capsular tropism.

PolysaccharideCapsulePredictive Ability

In a new blog post, Alima Yahia (a student at The Knowledge Society starting at Columbia University this Fall) explores phages and why they’re needed — including her own challenges with antibiotics. This is a fun, refreshing read; great work Alima!

BlogPhage therapy

Latest Jobs

Sponsored Ad Genome engineeringBioinformaticsBiochemistry
At Eligo Bioscience (Paris, France), we are passionate about developing new drugs to address microbiome-associated unmet medical needs, as highlighted by our recent publication in Nature.

To join our team and bring our exciting technology to the clinic, we are currently seeking:

• A Senior biochemist scientist to perform phage-derived particles manufacturing and process development
• A Microbial synthetic biologist to engineer non-model bacteria and phages
• A Bioinformatics scientist to help characterize target bacteria and improve the design of our phage particles

Join us as we build the future of precision microbiome medicines!

PostdocMolecular biologyRNA phages
The lab of Dr. David Wang at Washington University Medical Campus, St. Louis, USA is hiring a postdoc to conduct research in Molecular Microbiology with a focus on RNA phage biology.
Phage therapyBiotechScientist
ePhective (San Francisco) is a newly founded phage therapy company started by Joe Bondy-Denomy from UCSF and Zemer Gitai from Princeton. They are currently looking for:

  • Two Phage Scientists to lead projects in phage discovery, characterization, and engineering
  • Two Research Associates to contribute to perform hands-on microbiology and molecular biology work

Send your resume, cover letter, and a brief statement about why you’re excited about phage therapy to [email protected]. Use the subject line “[Job Title] Application – [Your Name]”.

Community Board

Anyone can post a message to the phage community — and it could be anything from collaboration requests, post-doc searches, sequencing help — just ask!

Ely O. Aboka of the Phage Hunters Training and Research Program in Nairobi, Kenya will host a LinkedIn Live panel discussion on July 31st, 2024 from 9:00 PM EAT on the topic ‘Antimicrobial Resistance (AMR) & Phage Therapy.’ Panelists include Prof. Steffanie Strathdee, Dr. Sabrina Green, and Christopher Shaffer, with Dr. Atunga serving as the session moderator.

Antimicrobial ResistancePhage TherapyPanel Discussion

The 14th annual Oxford Phage Conference will be held September 2-3, 2024 in Oxford, UK as a hybrid event.

Confirmed speakers include Professor Martha Clokie (UK) | Professor Aidan Coffey (Ireland) | Dr Mariam Dadiani (Georgia) | Professor Heather Allison (UK) | Professor David Gally (UK) | Dr Janine Bowring (Denmark) | Dr Antonia Sagona (UK) | Dr Sabrina Green (Belgium) | Dr Christian Fitch (UK) | Professor Paul Bollyky (USA).

See also the conference organizer’s youtube channel for past talks.

Phage biologyConferenceHybrid

Want to submit a session proposal for #ASMicrobe 2025 (particularly in the field of microbial ecology, evolution, and genomics)? The deadline is in a week! Submit your proposal here.

ConferenceSubmissions openMicrobial ecology

C&T Round Up for July 2024!

Profile Image
Product designer and co-founder of Phage Directory
Co-founderProduct Designer
Twitter @yawnxyz
Skills

Bioinformatics, Data Science, UX Design, Full-stack Engineering

I am a co-founder of Phage Directory, and have a Master of Human-Computer Interaction degree from Carnegie Mellon University and a computer science and psychology background from UMBC.

For Phage Directory, I design and build tools, and help write and organize Capsid & Tail.

I’ve previously worked at the Westmead Institute, for the Iredell lab at Phage Australia. There, I helped connect bioinformatics outputs and databases like REDCap, Google Drive, and S3-compatible storage systems.

Currently, I’m building and designing AI-centric tools for biology, including experimenting with protein models, biobank databases, AI-supported schema and data parsing, and bioinformatics workflows. Hit me up at [email protected] if you’re curious to collaborate!

Happy Summer!

I hope everyone’s been enjoying the summer heat that’s apparently been sweeping the country (and the world)! Even SF is getting “hotter” at a nice 21-22°C. Though down around Stanford it’s closer to 29°C… which is why I don’t go there too much.

For July, both Jessica and I have been getting a ton of work done! While she’s been wrangling protocols and prepping the lab for more phage work, I’ve been helping her build a spreadsheet-based research assistant tool.

My research assistant tool currently does things like search Pubmed and can “ask AI” the same question across 100+ papers — e.g. “what phage purification methods were used”.

It also creates better summaries and abstracts based on papers’ discussion and methods sections. Oh, and as a bonus — it can translate any journal article into any language — like Japanese or Spanish — and then read the entire article in that language.

I’ll do a longer write-up next week on how both Jess and I use my research assistant tool! And we’ll slowly roll it out to everyone in the next few weeks.

(If you want quicker access, email me at [email protected])

~ Jan

Here’s what we’ve covered this month:

Building on the shoulders of phage giants

by Bishoy Maher Zaki

In this article, Bishoy discussed his journey from phage isolation to bioinformatics, highlighting his current efforts to streamline phage genome analysis tools for the research community. He emphasized the importance of collaboration within the phage bioinformatics community and launched a survey to gather input on preferred tools, aiming to create a comprehensive resource for researchers — if you have a chance, please fill out his survey!

Additionally, the article addressed urgent requests for specific phages needed for patients in the UK and Belgium, showcasing the ongoing need for phage therapy in clinical settings.


Our Phage Picks for July 2024!

by Jan Zheng, Jessica Sacher

This month’s Phage Picks were a treasure trove of exciting research!

I highlighted an article on how AI has transformed protein science, hinting at the future of computational biology in the phage field. This is a slight departure from previous Picks as it’s not a phage journal article, but I feel is very important for the field nonetheless.

Jess shared an in-depth protocol from the Israeli Phage Therapy Center, detailing their comprehensive approach to phage therapy, which she found particularly inspiring.

We also explored a high-throughput method for detecting and characterizing phages, a study on mobile genetic elements in bacterial immunity, and a paper discussing a phage tail-like bacteriocin that could lead to targeted antimicrobials.

I think the phage field has really been hitting its stride in the last year, and there’s so many great papers getting published every week.


N of 1 trials vs. compassionate use for phage therapy

by Jessica Sacher

In this article, Jessica explored the distinctions between n of 1 clinical trials and compassionate use in the context of phage therapy. She reflected on her initial confusion regarding the two concepts, noting that while compassionate use aims to provide unapproved treatments to patients in need, n of 1 trials are structured clinical studies where a single patient serves as their own control.

She then highlighted the challenges of applying n of 1 trials to phage therapy, particularly due to the complexities of bacterial infections and treatment interactions. She also mentioned a recent n of 1 trial conducted in Canada, expressing interest in learning more about its design and outcomes.

To wrap up the article, Jess wondered whether n of 1 trials could offer a viable alternative to traditional clinical trials in the phage therapy landscape, especially given the difficulties in recruiting sufficient patients for larger studies.


C&T Throwback!

Since Jessica’s been up to her neck in phage production protocols, I thought it’d be nice to re-read Kyle Jackson’s post on how JAFRAL does phage production consistently and repeatably.

Producing phages consistently: then and now

Capsid & Tail

Follow Capsid & Tail, the periodical that reports the latest news from the phage therapy and research community.

We send Phage Alerts to the community when doctors require phages to treat their patient’s infections. If you need phages, please email us.

Sign up for Phage Alerts

In collaboration with

Mary Ann Liebert PHAGE

Supported by

Leona M. and Harry B. Helmsley Charitable Trust

Crossref Member Badge